Dr. David Shu is the regional division head of endocrinology for Fraser Health and vice president of the New Westminster Endocrine and Diabetes Research Society, as well as site leader for the UBC undergraduate internal medicine program.
Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomized, treat-to-target clinical trial. Helena W Rodbard, Virginia E Visco, Henning Andersen, Line C Hiort, David HW Shu. Lancet Diabetes and Endocrinology. Jan 2014. pp 30-37.